Efficacy and safety of topical WBI-1001 in the treatment of atopic dermatitis: results from a phase 2A, randomized, placebo-controlled clinical trial.

Saved in:
Bibliographic Details
Title: Efficacy and safety of topical WBI-1001 in the treatment of atopic dermatitis: results from a phase 2A, randomized, placebo-controlled clinical trial.
Authors: Bissonnette R, Chen G, Bolduc C, Maari C, Lyle M, Tang L, Webster J, Zhou Y
Source: Archives of dermatology [Arch Dermatol] 2010 Apr; Vol. 146 (4), pp. 446-9.
Publication Type: Clinical Trial, Phase II; Letter; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Medical Assn Country of Publication: United States NLM ID: 0372433 Publication Model: Print Cited Medium: Internet ISSN: 1538-3652 (Electronic) Linking ISSN: 0003987X NLM ISO Abbreviation: Arch Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1538-3652
DOI:10.1001/archdermatol.2010.34